Interferon alpha (IFN) and cyclic intensive chemotherapy (CIC) for chronic phase (CP) chronic myelogenous leukemia (CML).

被引：0
|
作者：
Giles, FJ [1 ]
Talpaz, M [1 ]
O'Brien, SM [1 ]
Rios, MB [1 ]
Kantarjian, HM [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4436
引用
收藏
页码：274B / 274B
页数：1
相关论文
共 50 条
  • [1] Early treatment decisions with interferon alpha (IFN-A) therapy in early chronic phase chronic myelogenous leukemia (CP-CML).
    Sacchi, S
    Kantarjian, K
    Smith, T
    OBrien, S
    Pierce, S
    Kornblau, S
    Beran, M
    Keating, M
    Talpaz, M
    [J]. BLOOD, 1997, 90 (10) : 2303 - 2303
  • [2] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    [J]. BLOOD, 1999, 94 (10) : 279B - 279B
  • [3] COMBINED MODALITY THERAPY WITH INTENSIVE CHEMOTHERAPY (DOAP) FOLLOWED BY ALPHA-INTERFERON (IFN-A) MAINTENANCE IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, HM
    TALPAZ, M
    KEATING, MJ
    WALTERS, RS
    MCCREDIE, KB
    FREIREICH, EJ
    GUTTERMAN, JU
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 210 - 210
  • [4] TRANSPLANTATION REGIMENS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN CHRONIC PHASE (CP)
    CLIFT, RA
    BUCKNER, CD
    STORB, R
    THOMAS, ED
    [J]. EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 501 - 501
  • [5] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL WITH ALPHA-INTERFERON (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    SMITH, T
    OBRIEN, S
    ROBERTSON, L
    KOLLER, C
    BERAN, M
    KEATING, M
    TALPAZ, M
    [J]. BLOOD, 1993, 82 (10) : A378 - A378
  • [6] Pilot study of interferon alpha receptor (IFN alpha R) expression in patients with chronic myelogenous leukemia (CML).
    Spielberger, R
    Snyder, D
    Forman, SJ
    Niland, J
    Nunez, R
    Domanski, PI
    Colamonici, O
    [J]. BLOOD, 1995, 86 (10) : 2100 - 2100
  • [7] Gene transfer of alpha interferon (IFN-alpha) into hematopoietic stem cells in chronic myelogenous leukemia (CML).
    Abraham, NG
    Cook, P
    Feldman, E
    Ahmed, T
    [J]. EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 157 - 157
  • [8] Retrospective comparison of imatinib versus interferon plus cytarabine (IFN/Ara-c) for chronic myelogenous leukemia (CML) patients in chronic phase (CP).
    Guilhot, F
    Roy, L
    Guilhot, J
    Krahnke, T
    Guerci, A
    Druker, B
    Larson, R
    O'Brien, S
    So, C
    Massimini, G
    [J]. BLOOD, 2005, 106 (11) : 52A - 52A
  • [9] Sudden elastic phase (SBP) transformation in the first 2 years (yrs) of interferon-α (IFN) therapy (RX) for chronic phase (CP) chronic myelogenous leukemia (CML).
    Thomas, D
    Kantarjian, H
    O'Brien, S
    Cortes, J
    Giles, FJ
    Faderl, S
    Rios, M
    Keating, M
    Talpaz, M
    [J]. BLOOD, 1998, 92 (10) : 251A - 251A
  • [10] Long-term follow-up results of alpha-interferon (alpha-IFN)-based regimens in patients with late chronic phase chronic myelogenous leukemia (CP-CML).
    Sacchi, S
    Kantarjian, H
    OBrien, S
    Keating, M
    Freireich, E
    Talpaz, M
    [J]. BLOOD, 1996, 88 (10) : 3531 - 3531
12345